Search results for Rapamycin

Latest updates for Rapamycin

Fresh curated links around Rapamycin are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fightaging.org /1 month ago

Academic Clinical Trials for Rapamycin to Answer Questions on Dosing for Anti-Aging Use

Rapamycin is increasingly prescribed off-label by anti-aging physicians based on animal studies and very limited human data (even including the relatively recent crowdfunded PEARL...

Read source

lifespan.io /1 month ago

Rapamycin Might Blunt Exercise Response in Humans

According to a new study, rapamycin probably interferes with exercise, blunting its effects in older human subjects. This result, however, might be specific to the particular proto...

Read source

peterattiamd.com /4 weeks ago

Disappointing results from the first rapamycin-plus-exercise trial

Why a single negative trial hasn’t diminished my interest in rapamycin as a potential geroprotector The post Disappointing results from the first rapamycin-plus-exercise trial appe...

Read source

genengnews.com /1 month ago

Neuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling

Preclinical study showed that neuronal nitric oxide synthase drives neuroblastoma through the mTOR signaling cascade, and that selectively inhibiting the enzyme using an inhibitor,...

Read source

bioengineer.org /1 month ago

RagC Detects β-Hydroxybutyrate Levels to Inhibit mTORC1 Activity and Tumor Progression

In recent years, the ketogenic diet has gained widespread attention not only as a weight-loss strategy but also as a potential adjunct therapy in cancer treatment. Among the many p...

Read source

fiercebiotech.com /1 month ago

Revolution’s much-hyped RAS inhibitor hits key survival goals in phase 3 pancreatic cancer trial

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of...

Read source

fightaging.org /1 month ago

First Human Data for Rubedo Life Sciences' Senolytic Drug RLS-1496

New senolytic drugs to clear the accumulation of senescent cells in aged tissues are working their way into clinical trials at the usual slow pace for medical development, slowed e...

Read source

cbsnews.com /2 weeks ago

FDA blocked melanoma drug as confusion reigned under Makary

A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.

Read source

labiotech.eu /1 week ago

RAS inhibition enters its second wave

Delve into the field of RAS inhibitors, an area of biotechnology that is increasingly diversifying to tackle pancreatic cancer, among other cancers. The post RAS inhibition enters...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.